• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Linde plc (Amendment)

    2/13/24 1:23:13 PM ET
    $LIN
    Major Chemicals
    Industrials
    Get the next $LIN alert in real time by email
    SC 13G/A 1 ie00bz12wp82_021324.txt ie00bz12wp82_021324.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 14) Linde plc -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) BNZHB81 -------------------------------------------------------- (SEDOL Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SEDOL No. BNZHB81 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 31962479 (6) Shared voting power 0 (7) Sole dispositive power 35119116 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 35119116 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 7.2% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- Linde plc Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- Forge 43 Church Street West Woking Surrey United Kingdom GU21 6HT Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or, if none, residence: ----------------------------------------------------------------------- BlackRock, Inc. 50 Hudson Yards New York, NY 10001 2(c) Citizenship: -------------------------------------------------------------------- See Item 4 of Cover Page 2(d) Title of class of securities: ------------------------------------------------------------------- Common Stock 2(e) SEDOL No.: See Cover Page Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: [ ] Broker or dealer registered under Section 15 of the Act; [ ] Bank as defined in Section 3(a)(6) of the Act; [ ] Insurance company as defined in Section 3(a)(19) of the Act; [ ] Investment company registered under Section 8 of the Investment Company Act of 1940; [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); [X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; [ ] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. Amount beneficially owned: 35119116 Percent of class 7.2% Number of shares as to which such person has: Sole power to vote or to direct the vote 31962479 Shared power to vote or to direct the vote 0 Sole power to dispose or to direct the disposition of 35119116 Shared power to dispose or to direct the disposition of 0 Item 5. Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ]. Item 6. Ownership of More than 5 Percent on Behalf of Another Person If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of Linde plc. No one person's interest in the common stock of Linde plc is more than five percent of the total outstanding common shares. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. See Exhibit A Item 8. Identification and Classification of Members of the Group If a group has filed this schedule pursuant to Rule 13d-1(b)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group. Item 9. Notice of Dissolution of Group Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Item 10. Certifications By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 13, 2024 BlackRock, Inc. Signature: Spencer Fleming ------------------------------------------- Name/Title Attorney-In-Fact The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001). Exhibit A Subsidiary Aperio Group, LLC BlackRock (Luxembourg) S.A. BlackRock (Netherlands) B.V. BlackRock (Singapore) Limited BlackRock Advisors (UK) Limited BlackRock Advisors, LLC BlackRock Asset Management Canada Limited BlackRock Asset Management Deutschland AG BlackRock Asset Management Ireland Limited BlackRock Asset Management North Asia Limited BlackRock Asset Management Schweiz AG BlackRock Financial Management, Inc. BlackRock Fund Advisors BlackRock Fund Managers Ltd BlackRock Institutional Trust Company, National Association BlackRock International Limited BlackRock Investment Management (Australia) Limited BlackRock Investment Management (UK) Limited BlackRock Investment Management, LLC BlackRock Japan Co., Ltd. BlackRock Life Limited *Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Exhibit B POWER OF ATTORNEY The undersigned, BlackRock, Inc., a corporation duly organized under the laws of the State of Delaware, United States (the "Company"), does hereby make, constitute and appoint each of Eric Andruczyk, Richard Cundiff, R. Andrew Dickson, III, Spencer Fleming, Daniel Goldmintz, Laura Hildner, Elizabeth Kogut, David Maryles, Christopher Meade, Una Neary, Charles Park, Daniel Riemer, David Rothenberg and Brenda Schulz, acting severally, as its true and lawful attorneys-in-fact, for the purpose of, from time to time, executing, in its name and on its behalf and on behalf of its direct and indirect subsidiaries, any and all documents, certificates, instruments, statements, filings, agreements and amendments (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including, without limitation, Schedules 13D and 13G and Forms 3, 4, 5, 13F and 13H and any amendments to any of the foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental or regulatory authority or other person, and giving and granting to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully and to all intents and purposes as the Company and/or its direct and indirect subsidiaries, as applicable, might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall expressly revoke the power of attorney dated 2nd day of January, 2019 in respect of the subject matter hereof, shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 30th day of April, 2023. BlackRock, Inc. By: /s/ R. Andrew Dickson, III Name: R. Andrew Dickson, III Title: Corporate Secretary
    Get the next $LIN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LIN

    DatePrice TargetRatingAnalyst
    1/13/2025Hold → Buy
    TD Cowen
    4/18/2024$510.00Neutral → Buy
    Mizuho
    4/10/2024$475.00 → $500.00Buy → Neutral
    Citigroup
    3/27/2024$482.00 → $510.00Buy → Neutral
    UBS
    3/1/2024Peer Perform
    Wolfe Research
    2/16/2024$395.00 → $455.00Market Perform
    TD Cowen
    1/22/2024$429.00Buy → Hold
    Stifel
    1/8/2024Buy → Neutral
    Seaport Research Partners
    More analyst ratings

    $LIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Linde plc upgraded by TD Cowen

      TD Cowen upgraded Linde plc from Hold to Buy

      1/13/25 8:21:47 AM ET
      $LIN
      Major Chemicals
      Industrials
    • Linde plc upgraded by Mizuho with a new price target

      Mizuho upgraded Linde plc from Neutral to Buy and set a new price target of $510.00

      4/18/24 7:34:08 AM ET
      $LIN
      Major Chemicals
      Industrials
    • Linde plc downgraded by Citigroup with a new price target

      Citigroup downgraded Linde plc from Buy to Neutral and set a new price target of $500.00 from $475.00 previously

      4/10/24 8:43:22 AM ET
      $LIN
      Major Chemicals
      Industrials

    $LIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Linde plc (Amendment)

      SC 13G/A - LINDE PLC (0001707925) (Subject)

      2/13/24 4:55:49 PM ET
      $LIN
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Linde plc (Amendment)

      SC 13G/A - LINDE PLC (0001707925) (Subject)

      2/13/24 1:23:13 PM ET
      $LIN
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Linde plc (Amendment)

      SC 13G/A - LINDE PLC (0001707925) (Subject)

      2/9/23 10:54:48 AM ET
      $LIN
      Major Chemicals
      Industrials

    $LIN
    SEC Filings

    See more
    • SEC Form 10-Q filed by Linde plc

      10-Q - LINDE PLC (0001707925) (Filer)

      5/1/25 10:21:30 AM ET
      $LIN
      Major Chemicals
      Industrials
    • Linde plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - LINDE PLC (0001707925) (Filer)

      5/1/25 7:11:34 AM ET
      $LIN
      Major Chemicals
      Industrials
    • SEC Form DEFA14A filed by Linde plc

      DEFA14A - LINDE PLC (0001707925) (Filer)

      4/30/25 3:05:16 PM ET
      $LIN
      Major Chemicals
      Industrials

    $LIN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Linde Reports First-Quarter 2025 Results

      First-Quarter Highlights Sales $8.1 billion, flat YoY, underlying sales up 1% Operating profit $2.2 billion, adjusted operating profit $2.4 billion, up 4% Operating profit margin 26.9%; adjusted operating profit margin 30.1%, up 120 basis points EPS $3.51, up 5%; adjusted EPS $3.95, up 5% YoY or 8% ex. FX First-quarter operating cash flow of $2.2 billion, up 11% versus prior year Full-year 2025 adjusted EPS guidance of $16.20 - $16.50 representing 4% to 6%, or 6% to 8% ex. FX, growth year-over-year Linde plc (NASDAQ:LIN) today reported first-quarter 2025 net income of $1,673 million and diluted earnings per share of $3.51, up 3% and 5% respectively. Excluding Linde AG purchase

      5/1/25 7:40:00 AM ET
      $LIN
      Major Chemicals
      Industrials
    • Linde to Expand Supply of Industrial Gases to Samsung in South Korea

      Linde (NASDAQ:LIN) announced today that it will increase its supply of ultra-high-purity atmospheric, process and specialty gases to Samsung's world-class semiconductor manufacturing complex in Pyeongtaek, South Korea. Linde is the main supplier of industrial gases to Samsung's complex at Pyeongtaek and already has multiple on-site facilities supplying essential gases. Under a new agreement, Linde will build, own and operate an eighth on-site air separation unit to supply nitrogen, oxygen and argon. Linde will also supply Samsung with hydrogen from its existing on-site hydrogen production facilities. Supply is expected to start up mid-2026. "Today's announcement further consolidates Linde

      4/29/25 7:03:00 AM ET
      $LIN
      Major Chemicals
      Industrials
    • Linde Declares Dividend in Second Quarter 2025

      Linde plc (NASDAQ:LIN) announced its Board of Directors has declared a quarterly dividend of $1.50 per share. The dividend is payable on June 18, 2025 to shareholders of record on June 4, 2025. About Linde Linde is a leading global industrial gases and engineering company with 2024 sales of $33 billion. We live our mission of making our world more productive every day by providing high-quality solutions, technologies and services which are making our customers more successful and helping to sustain, decarbonize and protect our planet. The company serves a variety of end markets such as chemicals & energy, food & beverage, electronics, healthcare, manufacturing, metals and mining. Linde'

      4/28/25 3:25:00 PM ET
      $LIN
      Major Chemicals
      Industrials

    $LIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Grant Hugh

      4 - LINDE PLC (0001707925) (Issuer)

      4/2/25 4:38:46 PM ET
      $LIN
      Major Chemicals
      Industrials
    • SEC Form 4 filed by Director Reynolds Paula Rosput

      4 - LINDE PLC (0001707925) (Issuer)

      4/2/25 4:35:40 PM ET
      $LIN
      Major Chemicals
      Industrials
    • Exec VP & Chief Legal Officer Bichara Guillermo sold $2,231,154 worth of Ordinary Shares (4,833 units at $461.65), decreasing direct ownership by 18% to 22,778 units (SEC Form 4)

      4 - LINDE PLC (0001707925) (Issuer)

      3/12/25 5:17:35 PM ET
      $LIN
      Major Chemicals
      Industrials

    $LIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Reynolds Paula Rosput bought $44,134 worth of Ordinary Shares (100 units at $441.34), increasing direct ownership by 75% to 233 units (SEC Form 4)

      4 - LINDE PLC (0001707925) (Issuer)

      12/12/24 2:22:03 PM ET
      $LIN
      Major Chemicals
      Industrials

    $LIN
    Financials

    Live finance-specific insights

    See more
    • Linde Reports First-Quarter 2025 Results

      First-Quarter Highlights Sales $8.1 billion, flat YoY, underlying sales up 1% Operating profit $2.2 billion, adjusted operating profit $2.4 billion, up 4% Operating profit margin 26.9%; adjusted operating profit margin 30.1%, up 120 basis points EPS $3.51, up 5%; adjusted EPS $3.95, up 5% YoY or 8% ex. FX First-quarter operating cash flow of $2.2 billion, up 11% versus prior year Full-year 2025 adjusted EPS guidance of $16.20 - $16.50 representing 4% to 6%, or 6% to 8% ex. FX, growth year-over-year Linde plc (NASDAQ:LIN) today reported first-quarter 2025 net income of $1,673 million and diluted earnings per share of $3.51, up 3% and 5% respectively. Excluding Linde AG purchase

      5/1/25 7:40:00 AM ET
      $LIN
      Major Chemicals
      Industrials
    • Linde Declares Dividend in Second Quarter 2025

      Linde plc (NASDAQ:LIN) announced its Board of Directors has declared a quarterly dividend of $1.50 per share. The dividend is payable on June 18, 2025 to shareholders of record on June 4, 2025. About Linde Linde is a leading global industrial gases and engineering company with 2024 sales of $33 billion. We live our mission of making our world more productive every day by providing high-quality solutions, technologies and services which are making our customers more successful and helping to sustain, decarbonize and protect our planet. The company serves a variety of end markets such as chemicals & energy, food & beverage, electronics, healthcare, manufacturing, metals and mining. Linde'

      4/28/25 3:25:00 PM ET
      $LIN
      Major Chemicals
      Industrials
    • Linde Announces Fourth Quarter 2024 Earnings and Conference Call Schedule

      WOKING, UK / ACCESSWIRE / January 9, 2025 / Linde (NASDAQ:LIN) will release its fourth quarter 2024 financial results by 06:00 EST/midday CET on Thursday, February 6, 2025. The Company will host and webcast its conference call at 09:00 EST/15:00 CET, which will be available to the public and the media in listen-only mode.Live conference callUS Toll-Free Dial-In Number: 1 888 770 7292UK Toll-Free Dial-In Number: 0800 358 0970Access code: 6877110 Live webcast (listen-only) https://www.linde.com/investors/financial-reports Web replay Available on demand beginning at 10:30 EST/16:30 CET onThursday, February 6, 2025, at:https://www.linde.com/investors/financial-reportsThe earnings release and pre

      1/9/25 6:20:00 AM ET
      $LIN
      Major Chemicals
      Industrials

    $LIN
    Leadership Updates

    Live Leadership Updates

    See more
    • Linde plc to Join the Nasdaq-100 Index® Beginning March 18, 2024

      NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Linde plc (NASDAQ:LIN), will become a component of the Nasdaq-100 Index® (NASDAQ:NDX), the Nasdaq-100 Equal Weighted™ Index (NASDAQ:NDXE), the Nasdaq-100 Ex-Tech Sector™ Index (NASDAQ:NDXX), and the Nasdaq-100 ESG™ Index (NASDAQ:NDXESG) prior to market open on Monday, March 18, 2024. Linde plc will replace Splunk Inc. (NASDAQ:SPLK) in the Nasdaq-100 Index® and the Nasdaq-100 Equal Weighted™ Index. Splunk will also be removed from the Nasdaq-100 ESG™ Index (NASDAQ:NDXESG) and the Nasdaq-100 Tech Sector™ Index (NASDAQ:NDXT) on the same date. For more information about the company, go to https://www.lind

      3/8/24 8:00:00 PM ET
      $LIN
      $NDAQ
      $SPLK
      Major Chemicals
      Industrials
      Investment Bankers/Brokers/Service
      Finance